Data Analytics In Healthcare Diversion Prevention, Detection and Response Quality Improvement

Similar documents
Patient Safety. Road Map to Controlled Substance Diversion Prevention

Understanding Diversion in the Pharmacy Kimberly S. New JD BSN RN

Drug Diversion Prevention The Mayo Clinic Experience

Not if, but When: Drug Diversion in Hospitals. Christopher Fortier, PharmD, FASHP Chief Pharmacy Officer Massachusetts General Hospital Boston, MA

Understanding Diversion

Medication Diversion and Prescription Drug Abuse in the Long Term Care Setting. Objectives

A Million Little Pieces: Developing a Controlled Substance Diversion Program. Tanya Y. Barnhart, PharmD, BCPS

Pharmaceutical Diversion Prevention, Detection and Incident Response

10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure

Medication Management and Diversion Control

AHLA. T. Diversion of Controlled Substance in Health Care Setting

BEST PRACTICES: DOCUMENTATION OF CLINICAL RATIONALE FOR CHRONIC OPIOID THERAPY THE LEGAL PERSPECTIVE PART I. The presentation was created by

RxStation: Cerner s Medication Dispensing Cabinet

Drug Distribution Services for Long Term Care Facilities. Susan L. Lakey, PharmD 1/11/06

THE BASICS THE BASICS STAFF EDUCATION DRUG DIVERSION TASK FORCE 4/8/2016. MSHP Annual Meeting 2016

SECTION 1: PROCESS FOR NEW/ANNUAL RENEWAL OF MED AGREEMENT:

Medication Reconciliation

It s every OR manager s nightmare a drug diversion that hits the local

Critical Access Hospitals Site Visit Summary Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital

(b) Service consultation. The facility must employ or obtain the services of a licensed pharmacist who-

ROUND LAKE Journey Toward Healthy. Treatment Centre

a remote pharmacy is not necessarily intended to provide permanent??? how do we make it so that it may be only for limited duration.

Case Study: Unit-Dose Implementation at the Ross Memorial Hospital Slow but Sure, Through Small Cycles of Change

PACKAGING, STORAGE, INFECTION CONTROL AND ACCOUNTABILITY (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:

From Big Data to Big Knowledge Optimizing Medication Management

Georgia DPH. Prescription Title Drug Heading Monitoring Program Program. Sheila Pierce April 2018

eprescribe Training for Nurses and Pharmacy Techs Net Access Home Medication Pathway Clinical Informatics - Oct 2015

Using the Just Culture Method. Stacey Thomas, BSN, RNC Risk Analyst

Development of a Road Map to Controlled Substance Diversion Prevention

NEW MEXICO PRACTITIONER S MANUAL

PHARMACEUTICALS AND MEDICATIONS

Pharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A.

MEDCOM Medication Management Discussion

Prepared for the Foundation of the American College of Healthcare Executives Session 101AB Not If, but When: Drug Diversion in Hospitals

Optimizing Medication Safety in Maryland Assisted Living Facilities. Panel Discussion Moderated by: Nicole Brandt, PharmD

Scope of the Problem. Leadership Engagement. Leadership Engagement. Risk of Harm to Patients. Risk of Harm to Patients 6/13/2016

Introduction to Pharmacy Practice

Prescription Drug Monitoring Program (PDMP)

H2H Mind Your Meds "Challenge. Webinar #3- Lessons Learned Wednesday, April 18, :00 pm 3:00 pm ET. Welcome

PREPARATION AND ADMINISTRATION

Frequently Asked Questions

Medication Module Tutorial

2018 Plan Year State Employees Prescription Drug Plan

Consultant ID: Team Lead Pharmacy/Meds Process Health System April October 2016

Staff Responsible Procedure Rationale/Reason

Drug Diversion Exercise. New Jersey Department of Health Pilot Project-Safe Injection Practices January/February 2016

Disclosures. Exploration of Telepharmacy: History of Telepharmacy 8/14/2014. Pharmacist and Technician Objectives

C. Physician s orders for medication, treatment, care and diet shall be reviewed and reordered no less frequently than every two (2) months.

CPhT Program Recognition Attestation Form

STATE OF MICHIGAN DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS BUREAU OF PROFESSIONAL LICENSING BOARD OF PHARMACY DISCIPLINARY SUBCOMMITTEE

Kimberly S. New RN BSN JD Compliance Specialist University of Tennessee Medical Center

Identifying and Adopting an Integrated Solution that best fits you!!! Kumaravelu Country Manager

CareFusion Overview Scott Bostick SVP/GM Pyxis Dispensing Technologies

RFP APD Pharmaceutical Questions and Answers May 26, 2015

Profiles in CSP Insourcing: Tufts Medical Center

Management of Controlled Substances Ambulatory Care with Electronic Key Control Cabinet

Fairview Pharmacy Services, LLC. Beyond Central Fill: How Central Services Improves Efficiencies and Expands Offerings

Audience Poll Questions

Long Term Care Pharmacy

DC Board of Pharmacy and Pharmaceutical Control Update

100-28a-1a. Definitions. As used in this article, each of the following terms shall have the

Non-Physician i Providers

Michigan. Contact Information. State Registrant Totals and Population. PDMP name: MAPS

Quanum eprescribing Frequently Asked Questions

POLICIES, PENALTIES AND PROCEDURES

A Game Plan to Surviving a Joint Commission Survey. May Adra, BS Pharm, PharmD, BCPS

Pharmacies Medicare Part D Training Obligations and Medicare Training Resources

INDEX PAGE #1 of 3. Page # Resident's Name Name of Drug Page # Resident's Name Name of Drug

Homecare Salary & Benefits Report Job Descriptions. Salary Positions

Administrative Update: How to Implement Discharge Pharmacy Services (DPS) Objectives

9/15/2017. Nursing: Substance Use, Drug Diversion, and Recovery Nancy Rogers, MS, RN-BC, CASAC, CNE. Objectives. Substance Use Among Nurses

Nebraska Pharmacy Law 2015

The Introduction of Automated Medication Management and Dispensing System with Omnicell

Incident Action Plan Community Overdose Action Team (COAT)

PRESCRIBING IN NEVADA

Just Culture Toolkit Scenarios

Definitions: In this chapter, unless the context or subject matter otherwise requires:

Compliance Made Simple: 24/7/365

Dispensing error rates and impact of interruptions in a simulation setting.

Focus Group results RN Perspective

UW HEALTH JOB DESCRIPTION

Making the Most of the Guide to Minnesota Class F Home

InstyMeds Prescription Writer Tutorial

Robert J. Walters, Senior Assistant Attorney General Wyoming Attorney General s Office June 5, 2014

An Overview for Inpatient Pharmacies (e.g., hospitals, in-hospital hospices, and long-term care facilities that dispense for inpatient use)

Alaska. Contact Information. State Registrant Totals and Population. PDMP name: AKPDMP

Section 2 Medication Orders

247 CMR: BOARD OF REGISTRATION IN PHARMACY

Optimizing Medication Distribution using Automated Dispensing Cabinets

DC Board of Pharmacy and Pharmaceutical Control Update

Storage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431

Management of Controlled Substance

MINNESOTA. Downloaded January 2011

CHAPTER 18 CONTROLLED SUBSTANCES

Health Sciences Job Summaries

GENERAL DENTIST. Dental Receptionist Manual

Policies and Procedures for LTC

Medication Safety Technology The Good, the Bad and the Unintended Consequences

Programmatic Policy and Procedure

NOTES AND ACTIONS. Turn off power switch, wait a few seconds, turn back on. If paper jammed, remove and reinsert.

Transcription:

Data Analytics In Healthcare Diversion Prevention, Detection and Response Quality Improvement

This presentation will cover The Wake-up call How we incorporated data analytics into our diversion detection and prevention program The constantly evolving process of diversion detection, prevention and response in healthcare The unexpected outcome from data analytics Speaking up

A necessary part for all healthcare facilities Controlled substance medications are used for legitimate medical purposes thousands of times daily at hospitals and healthcare facilities all across the country Once we administer the anesthesia, you won t feel a thing.

A Wake up Call to Action Drug thefts at U-M hospital: A nurse's death, a doctor's overdose and 16,000 missing pills On a single day in December last year (2013) a nurse and doctor both overdosed on stolen pain medication in different areas of the sprawling University of Michigan Health System. By John Counts johncounts@mlive.com The Ann Arbor News October 26, 2014

Pre 2014 RN, MD OD UMHS ESTABLISH ACCOUNTABILITY STRUCTURE 2014 Controlled Substance Management Timeline Consultant Review ANES Diversion Prevention Work Group DEA Visit 2015 2016 Hire CS Safety & Compliance Manager Hire Diversion Prevention Manager Creation of CS Safety & Transition CS Oversight Committee Management to Program 2001 Privileged Practitioner Impairment Policy DEVELOP CS-RELATED POLICY & PROCEDURES ESTABLISH SYSTEMS TO MONITOR & REVIEW CS HANDLING ENHANCE DIVERSION PREVENTION/ DETECTION PROGRAM Fentanyl process Fentanyl process change change ANES Kit Reconciliation Post-Case Pandora system to ID outliers Drug-Free Workplace Policy For-Cause Testing (for all employees) Expansion of Pharmacy Reconciliation @ ORs Created CS Audit Plan for All Pharmacies Periodic audit of CS prescribing to identify high-volume prescribers ANES begins development of electronic tracking system Expansion of Impairment Policy to include all Medical School Faculty Drug Testing added to Background Check (for all employees) Institutional Controlled Substance Management Policy Expanded Camera Placements DEA Application for All Sites Compliance Hotline Script for Anonymous Reporting Documentation of CS Processes Across All Pharmacy Sites Random Assay Kit Testing ANES Kit-Per-Case Paper Reconciliation 40% reduction in discrepancies Add CS drop boxes off-site RX Destroyer Deployed for Waste SAM (Suspicious Activity Monitoring) Enhanced Random Testing Pilot Policy Drafted Pending Compliance Risk Rounding AnyWhere RN PHARM Tech Staffing Improvement Complete Audit Plan Developed Sharps Container Testing All CS Infusions CS-Tool Fully automated Bio ID-required Med Access IMPAIRMENT & DIVERSION RESPONSE Code N case determination EAP & HPRP monitoring of practitioners w/ past issues Formalize MRO (Medical Review Officer) in FCT process Attestation for Privileged Practitioners @ Appointment/Psychiatry Effort in OCA for FCT & Impairment Evaluation Develop Institutional FCT Process Standard 2011 OCA White Paper on Managing Impairment COMMUNICATE/ EDUCATE Opioid Conundrum Workshop CMO Newsletter to all staff Lecture on RNs & Substance Use Boot Camp on Impaired Practitioners 3 rd yr med student training E-mail to all staff on OD anniversary On site Diversion Prevention Conference National Association of Drug Diversion Investigators Conference Service Chief Workshop Development of Com Campaign MI OPEN Distribution of Speak Up. Save a Life video 112015

Suspicious Activity Monitoring Data Analytics A method of continuous real time review Does not exist in an easily obtainable form (frustration!!!!) Can be performed hourly, daily, weekly, monthly, etc ) May lead to identifying suspicious activities May be used to verify suspicious behavior by adding historical data that is linked to medication dispensing and administration Helps to identify quality improvement opportunities

Michigan Medicine Statistics Michigan Medicine experiences approximately 3 million patient visits per year Licensed as 1,000+ bed hospital Averaging 75,000 transactions / month (2,500 / day) from ADC (Automated Dispensing Cabinets) About 1,000 dispensing transactions daily from our 4 retail pharmacies Averaging 150 surgery cases /day Over 280 emergency department visits /day Approximately 26,000 employees including: 5,500 Nurses 1,300 House officers (physicians) 1,400 Resident physicians 200 Pharmacists 200 Pharmacy technicians 180 CRNA s 270 Anesthesiologists 200+ Researchers *

Data to Review Direct access employees = ~ 6,300 Indirect access employees =~ 5,000 Monthly Totals (approximates) 75,000 ADC transactions 100,000 emar Transactions 6,000 prescriptions (~ 30% of all scripts are CS) The risk!!! It is estimated that 12 16% of healthcare workers may have a substance abuse issue sometime in their career

The Data There are multiple ways of looking at data Each unique chart tells a story Combined together they tell a better story Combined with other information will help to verify the facts of the investigation

Following up with Data findings On the occasion that data findings indicate an unexplainable outlier or activity Actions that follow include: 1. A deeper dive into supporting data 2. Meeting with impacted management 3. Meeting and evaluation with cross function team 4. Meeting and interview with the responsible employee, HR, representation Outcomes range from Acceptable Explanation Obtained Assistance with a recovery program

Following up with Data Findings for CAPA Identifying improvement opportunities I wasted 50 of fentanyl in the Omnicell along with a co worker RN My co worker forgot to push the "waste med now" button, he said afterward he didn t know that was his responsibility to do so. After I got the notice of this issue, my co worker clearly stated that he did in fact witness me waste the medication. I helped the assigned RN to repositioning the pt. Afterward, we found a pill in pt's bed. RN looked up pill online, determined it was an Oxycodone, We notified charge RN, who then notified security and the Unit manager. Security picked up the pill. The housekeeper was sweeping under the patients bed and found two pills. RN was at bedside and the housekeeper gave the meds to the RN. The meds were brought to pharmacy and identified as 50 mg tramadol and 0.5 mg Ativan. The patient has an order for both of these medications PRN. Security was notified and came to take the meds. I took out one ampule of fentanyl and one vial of versed, from the Omnicell, for first case of the day. There was a delay in getting the Pt to the procedure room. I put the drugs in the top drawer of our nurse cart out of sight, during the procedure. We did not use these meds. I failed to return the drugs to the Omnicell. They were found later that day.

How We Used Prescribing Data University of Michigan OPEN (Opioid Prescribing Engagement Network)

Suspicious Activity Monitoring There are 2 types of activity monitoring taking place: 1. Data Analytics includes transactions from the ADC (automated dispensing machines), the patient medical records, prescriptions and anesthesia tracking system This monitoring is desk top and looks at transactional data from the dispensing units along with administration data from medical records. It helps to detect outlier transactions, high frequency transactions, wasting transactions and prescription quantities / rates 2. Behavioral monitoring includes observations made by coworkers, supervisors, managers, patients and visitors These are observations made pertaining to the activities of people inside of the facility (patients, employees and visitors) May lead to further investigation When possible, data analytics are used to support each investigation

Speaking up Michigan Medicine has produced this video to promote open communications and understanding of healthcare providers that encountered this issue Speak up Save a Life

Conclusions Collaborative Investigations Multiple types of investigations and observations are needed to detect controlled substance diversion and abuse in healthcare. Data analytics and behavioral observations lead the list and are co dependent and cosupportive A team of cross functional departments including Pharmacy, Nursing, Security, Safety and Compliance all contribute to the data analysis and outcome recommendations of the investigations Discoveries from these investigations may lead to opportunities that improve our systems and upgrade our skill sets while also helping to detect diversion

Questions Len Lewis Compliance Manager Controlled Substances Michigan Medicine University of Michigan lenlewis@med.umich.edu